The subject invention provides a method for optimal isolation of cimiracemate A for subsequent use as a therapeutic agent or dietary supplement in single entry or in combination with other treatment modalities. In addition, the subject invention discloses cimiracemate A as a bioactive marker that ca.....
[更多]
The Invention Provides A Method For Treating Cancers That Are Dependent On Cyclin D1 For Proliferation, Survival, Metastasis And Differentiation, Involving Administering A Composition Containing An Effective Amount Of Arsenic Trioxide To An Affected Patient. The Arsenic Trioxide Can Be Administered .....
[更多]
It has been discovered that As.sub.2O.sub.3 suppresses tyrosine kinase receptors, in particular EGFR and IL-6R, by targeting RTKs to lysosomes and/or proteasome for degradation. This is the basis for the discovery that cancers dependent on RTKs for signaling, proliferation, survival, metastasis and .....
[更多]
| |<首頁 <-上一頁 下一頁-> 末頁>| |
